Immune privilege in sites of chronic infection: Leishmania and regulatory T cells
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary: Leishmania are digenetic protozoan parasites that are inoculated into the skin by vector sand flies, are taken up by macrophages, and produce a spectrum of chronic diseases in their natural reservoir and susceptible human hosts. During the early establishment of infection in the skin and lymphoid organs, Leishmania produce multiple effects on macrophage and dendritic cell functions that inhibit their innate anti‐microbial defenses and impair their capacity to initiate T‐helper 1 cell immunity. In addition, the skin is a site preconditioned for early parasite survival by virtue of a high frequency of steady‐state, natural CD25+Foxp3+ regulatory T cells (Tregs) that function to suppress the generation of unneeded immune responses to infectious and non‐infectious antigens to which the skin is regularly exposed. In murine models of infection, antigen‐induced CD25+/−Foxp3−interleukin (IL)‐10+ Treg cells act during the effector phase of the immune response to control immunopathology and may also delay or prevent healing. Finally, following resolution of infection in healed mice, CD25+Foxp3+ Tregs function in an IL‐10‐dependent manner to prevent sterile cure and establish a long‐term state of functional immune privilege in the skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., & Sacks, D. L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1497 · Cited by 557 · cited 4×
“major chronic infection IL-10-producing cells detected during Leishmania infection are both exclusive IL-10 producers and IL-10/IFN-g double producers (178), suggesting that more than one population of IL-10-producing cells, with potentially different functions, exist during infection.”
BackgroundInfluentialSelf-citationRecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Nickoloff, B. J., & Nestle, F. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422147 · Cited by 544 · cited 1×
“Although the pathogenesis of psoriasis is not fully understood, clinical disease is likelymediated by self-specific effector T cells, which sustain a cycle of cytokine, chemokine, and growth factor production in a skin lesion that can resolve spontaneously (202).”
BackgroundLiew, F. Y., Li, Y., & Millott, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4306 · Cited by 522
The role of IL-10 in promoting disease progression in Leishmaniasis
Kane, M. M., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1141 · Cited by 514
Cutting Edge: Neutrophil Granulocyte Serves as a Vector for Leishmania Entry into Macrophages
van Zandbergen, G., Klinger, M., Mueller, A., Dannenberg, S., Gebert, A., Solbach, W., & Laskay, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6521 · Cited by 430
LANG, M. L., CHEN, Y.-W., SHEN, L., GAO, H., LANG, G. A., WADE, T. K., & WADE, W. F. (2002) · Biochemical Journal · doi:10.1042/bj20011696 · Cited by 60 · cited 1×
“As several proteins involved in membrane fusion, as well as the NADPH oxidase and various PKC isoenzymes, have all been shown to be present in lipid rafts (35, 36), the disruption of phagosome microdomains by LPG may explain the multiple effects that the parasite has on macrophage function.”
Background
Cited by
In Vivo Imaging Reveals an Essential Role for Neutrophils in Leishmaniasis Transmitted by Sand Flies
Peters, N. C., Egen, J. G., Secundino, N., Debrabant, A., Kimblin, N., Kamhawi, S., Lawyer, P., Fay, M. P., Germain, R. N., & Sacks, D. (2008) · Science · doi:10.1126/science.1159194 · Cited by 834
Self-citationLeishVet guidelines for the practical management of canine leishmaniosis
Solano-Gallego, L., Miró, G., Koutinas, A., Cardoso, L., Pennisi, M. G., Ferrer, L., Bourdeau, P., Oliva, G., & Baneth, G. (2011) · Parasites & Vectors · doi:10.1186/1756-3305-4-86 · Cited by 824
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Tone, Y., Furuuchi, K., Kojima, Y., Tykocinski, M. L., Greene, M. I., & Tone, M. (2008) · Nature Immunology · doi:10.1038/ni1549 · Cited by 807
Leishmaniasis emergence in Europe
Ready, P. D. (2010) · Eurosurveillance · doi:10.2807/ese.15.10.19505-en · Cited by 457
Creating immune privilege: active local suppression that benefits friends, but protects foes
Mellor, A. L., & Munn, D. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2233 · Cited by 327
Metadata
- Authors
- Peters, N., & Sacks, D.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2006-09-14
- Volume
- 213
- Issue
- 1
- Pages
- 159-179
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2082224040
- Cited by
- 132
- References
- 9
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. https://app.cochat.ai/papers/10.1111/j.1600-065x.2006.00432.x
- The paper
- Peters, N., & Sacks, D. (2006). Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunological Reviews. https://doi.org/10.1111/j.1600-065x.2006.00432.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.